Literature DB >> 16326701

Vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase.

Eleni S Stanitsa1, Lisa Arps, Paula Traktman.   

Abstract

The vaccinia virus E9 protein, the catalytic subunit of the DNA polymerase holoenzyme, is inherently distributive under physiological conditions, although infected cells contain a highly processive form of the enzyme. The viral A20 protein was previously characterized as a stoichiometric component of the processivity factor, and an interaction between A20 and E9 was documented in vivo. A20 has been shown to interact with D4, the virally encoded uracil DNA glycosylase (UDG), by yeast-two hybrid and in vitro analysis. Here we confirm that UDG and A20 interact in vivo and show that temperature-sensitive viruses with lesions in the D4R gene show a profound defect in DNA synthesis at the non-permissive temperature. Moreover, cytoplasmic extracts prepared from these infections lack processive polymerase activity in vitro, implicating D4 in the assembly or activity of the processive polymerase. Upon overexpression of 3xFLAG-UDG, A20, and E9 in various combinations, we purified dimeric and trimeric UDG-A20 and UDG-A20-polymerase complexes, respectively. These complexes are stable in 750 mm NaCl and can be further purified by Mono Q chromatography. Notably, the trimeric complex displays robust processive polymerase activity, and the dimeric complex can confer processivity on purified E9. Consistent with previous reports that the catalytic activity of UDG is dispensable for virus replication in tissue culture, we find that the role of UDG role in the polymerase complex is not diminished by mutations targeting residues involved in uracil recognition or excision. Our cumulative data support the conclusion that A20 and UDG form a heterodimeric processivity factor that associates with E9 to comprise the processive polymerase holoenzyme.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326701     DOI: 10.1074/jbc.M511239200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice.

Authors:  Graciela Andrei; Don B Gammon; Pierre Fiten; Erik De Clercq; Ghislain Opdenakker; Robert Snoeck; David H Evans
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.

Authors:  Sophie Duraffour; Graciela Andrei; Dimitri Topalis; Marcela Krečmerová; Jean-Marc Crance; Daniel Garin; Robert Snoeck
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Marker rescue mapping of the combined Condit/Dales collection of temperature-sensitive vaccinia virus mutants.

Authors:  Sayuri E M Kato; Nissin Moussatche; Susan M D'Costa; Travis W Bainbridge; Cindy Prins; Audra L Strahl; Amber N Shatzer; Alyson J Brinker; Nicole E Kay; Richard C Condit
Journal:  Virology       Date:  2008-03-07       Impact factor: 3.616

4.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

5.  Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach.

Authors:  Janice Elaine Y Silverman; Mihai Ciustea; Abigail M Druck Shudofsky; Florent Bender; Robert H Shoemaker; Robert P Ricciardi
Journal:  Antiviral Res       Date:  2008-06-20       Impact factor: 5.970

Review 6.  Poxvirus DNA replication.

Authors:  Bernard Moss
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 7.  The vaccinia virus DNA polymerase and its processivity factor.

Authors:  Maciej W Czarnecki; Paula Traktman
Journal:  Virus Res       Date:  2017-02-01       Impact factor: 3.303

Review 8.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

9.  Crystal Structure of the Vaccinia Virus Uracil-DNA Glycosylase in Complex with DNA.

Authors:  Wim P Burmeister; Nicolas Tarbouriech; Pascal Fender; Céline Contesto-Richefeu; Christophe N Peyrefitte; Frédéric Iseni
Journal:  J Biol Chem       Date:  2015-06-04       Impact factor: 5.157

10.  Vaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis.

Authors:  Susan M D'Costa; Travis W Bainbridge; Sayuri E Kato; Cindy Prins; Karen Kelley; Richard C Condit
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.